Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
News
Podcast
Novel HER2-low Therapies and Pharmacist-Led ADC Sequencing
Author(s):
This installment of our series on ADCs and HER2 breast cancer offers key insights about novel agents in clinical trials and management of ADC therapies.
In this episode of the Pharmacy Times Peer Exchange feature series about antibody drug conjugates (ADCs) and human epidermal growth factor receptor 2 (HER2) breast cancer (BC), oncology pharmacists continue their discussion and move onto emerging therapies in HER2-negative and HER2-low metastatic BC. Hosted by Rose DiMarco, they also share key insights about the role of pharmacists in guiding ADC therapy sequencing.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Videos
Related Content
